Jump to content

Search the hub

Showing results for tags 'Cancer'.

More search options

  • Search By Tags

    Start to type the tag you want to use, then select from the list.

  • Search By Author

Content Type


Forums

  • All
    • Commissioning, service provision and innovation in health and care
    • Coronavirus (COVID-19)
    • Culture
    • Improving patient safety
    • Investigations, risk management and legal issues
    • Leadership for patient safety
    • Organisations linked to patient safety (UK and beyond)
    • Patient engagement
    • Patient safety in health and care
    • Patient Safety Learning
    • Professionalising patient safety
    • Research, data and insight
    • Miscellaneous

Categories

  • Commissioning, service provision and innovation in health and care
    • Commissioning and funding patient safety
    • Digital health and care service provision
    • Health records and plans
    • Innovation programmes in health and care
    • Climate change/sustainability
  • Coronavirus (COVID-19)
    • Blogs
    • Data, research and statistics
    • Frontline insights during the pandemic
    • Good practice and useful resources
    • Guidance
    • Mental health
    • Exit strategies
    • Patient recovery
    • Questions around Government governance
  • Culture
    • Bullying and fear
    • Good practice
    • Occupational health and safety
    • Safety culture programmes
    • Second victim
    • Speak Up Guardians
    • Staff safety
    • Whistle blowing
  • Improving patient safety
    • Clinical governance and audits
    • Design for safety
    • Disasters averted/near misses
    • Equipment and facilities
    • Error traps
    • Health inequalities
    • Human factors (improving human performance in care delivery)
    • Improving systems of care
    • Implementation of improvements
    • International development and humanitarian
    • Safety stories
    • Stories from the front line
    • Workforce and resources
  • Investigations, risk management and legal issues
    • Investigations and complaints
    • Risk management and legal issues
  • Leadership for patient safety
    • Business case for patient safety
    • Boards
    • Clinical leadership
    • Exec teams
    • Inquiries
    • International reports
    • National/Governmental
    • Patient Safety Commissioner
    • Quality and safety reports
    • Techniques
    • Other
  • Organisations linked to patient safety (UK and beyond)
    • Government and ALB direction and guidance
    • International patient safety
    • Regulators and their regulations
  • Patient engagement
    • Consent and privacy
    • Harmed care patient pathways/post-incident pathways
    • How to engage for patient safety
    • Keeping patients safe
    • Patient-centred care
    • Patient Safety Partners
    • Patient stories
  • Patient safety in health and care
    • Care settings
    • Conditions
    • Diagnosis
    • High risk areas
    • Learning disabilities
    • Medication
    • Mental health
    • Men's health
    • Patient management
    • Social care
    • Transitions of care
    • Women's health
  • Patient Safety Learning
    • Patient Safety Learning campaigns
    • Patient Safety Learning documents
    • Patient Safety Standards
    • 2-minute Tuesdays
    • Patient Safety Learning Annual Conference 2019
    • Patient Safety Learning Annual Conference 2018
    • Patient Safety Learning Awards 2019
    • Patient Safety Learning Interviews
    • Patient Safety Learning webinars
  • Professionalising patient safety
    • Accreditation for patient safety
    • Competency framework
    • Medical students
    • Patient safety standards
    • Training & education
  • Research, data and insight
    • Data and insight
    • Research
  • Miscellaneous

News

  • News

Find results in...

Find results that contain...


Date Created

  • Start
    End

Last updated

  • Start
    End

Filter by number of...

Joined

  • Start

    End

Group

First name

Last name

Country

Join a private group (if appropriate)

About me

Organisation

Role

Found 541 results
  1. News Article
    Women affected by a review of cervical smears in the Southern Health Trust have said they are "angry, frustrated and scared" for their future. About 17,500 patients in the trust are to have their previous smears re-checked as part of a major review of cervical screening dating back to 2008. Some of these women will be recalled to have new smear tests carried out. But the process has not started yet and will take at least six months to complete. Letters were sent out by the trust earlier this month to those affected. The Southern Trust says it expects to recall around 4,000 women for a new smear test after it reviews 17,368 historic slides. The Trust's medical director, Dr Steve Austin, told its board meeting that the review of slides was expected to start next week. It also emerged that the number of calls from concerned women has increased with many asking for more "specialist" answers. Read full story Source: BBC News, 27 October 2023
  2. News Article
    About 17,500 women in Northern Ireland are to have their smear tests re-checked as part of a major review of cervical screening dating back to 2008. Some of these women will be recalled to have new smear tests carried out, BBC News NI can reveal. The Southern Trust said that the women affected should receive letters by post from Tuesday. It follows a highly critical report commissioned by the Royal College of Pathologists (RCPath). It found: Several cytology staff were "significantly underperforming". Mechanisms to check their work were flawed. Action taken by management was inadequate over many years. While a majority of negative results issued by the laboratory were correct, a "significant number" of these would likely have been identified as "potentially abnormal" by other laboratories. Read full story Source: BBC News, 9 October 2023
  3. News Article
    A woman has spoken of her "complete shock" at being misdiagnosed with cancer and undergoing surgery when she never had the condition at all. Megan Royle, 33, from East Yorkshire, was diagnosed with skin cancer in 2019. As part of her treatment, she underwent immunotherapy and her eggs were frozen due to the risk to her fertility. But after she was given the all-clear in 2021, a review showed she never had cancer and she has now won compensation from the two NHS trusts involved. Ms Royle, from Beverley, said: "You just can't really believe something like this can happen, and still to this day I've not had an explanation as to how and why it happened. "I spent two years believing I had cancer, went through all the treatment, and then was told there had been no cancer at all." "You'd think the immediate emotion would be relief and, in some sense, it was - but I'd say the greater emotions were frustration and anger." Read full story Source: BBC News, 18 October 2023
  4. News Article
    Thousands of patients in England and Northern Ireland are missing out on a life-extending prostate cancer drug that is more widely available on the NHS in Scotland and Wales, say experts. Charity Prostate Cancer UK said it was "unacceptable" that men in parts of the UK were facing a postcode lottery. Although not a cure, abiraterone can help stop prostate cancer spreading to other parts of the body. NHS England said it would review the drug's use for more men next year. Read full story Source: BBC News, 23 October 2023
  5. News Article
    A mother of two prescribed antidepressants after complaining of fatigue was devastated when she learned she had stage four bowel cancer and had just nine months to live. Helen Canning complained of anaemia and low energy for more than a year, but as a 37-year-old with two children under the age of five, her symptoms were put down to prolonged postnatal depression and work stress. “At the end of the school day, I’d sit at my desk and lose half an hour of my time just sitting and staring,” the A-level science teacher from Suffolk said. “I was so tired. Then I would get even more stressed because I was getting behind on my work.” She went to the GP because she was concerned about her symptoms. Despite being told her iron was low, she said she was never offered a blood test to investigate this further. As well as prescribing antidepressants, the GP referred her to a gynaecologist for an ultrasound scan on her left side in December 2020, but the scan did not detect anything. But less than a year later in August 2021, she was diagnosed with bowel cancer after she was rushed into A&E with a “crippling, stabbing pain” and violent vomiting, the night before her ninth wedding anniversary. She was told she had advanced colorectal cancer, a primary tumour in the right side of her colon, with secondary growths on her ovaries, liver, and peritoneum. Though Mrs Canning was given only nine months to live after her diagnosis, the mother of two leaned on her family for strength as she started chemotherapy. It has now been over two years and she continues to fight. Now she is determined to raise awareness of the common signs and symptoms of bowel cancer, and urges people to “know their own ‘normal’ and not be afraid to keep pushing for further testing and answers when doctors don’t”. Read full story Source: Independent, 22 October 2023
  6. News Article
    Women are being unnecessarily alarmed about their risk of breast cancer by consumer genetic test results that do not take family history into account, researchers have said. Women who discover outside a clinical setting that they carry a disease-causing variant of the BRCA1 or BRCA2 genes may be told that their risk of breast cancer is 60-80%. But analysis of UK Biobank data suggests the risk could be less than 20% for those who do not have a close relative with the condition. Dr Leigh Jackson, of the University of Exeter’s medical school, who is the lead author of the analysis published in the journal eClinical Medicine, said that in extreme cases this could result in women unnecessarily undergoing surgery. “Being told you are at high genetic risk of disease can really influence levels of fear of a particular condition and the resulting action you may take,” he said. “Up to 80% risk of developing breast cancer is very different from 20%.” Until recently, women who received BRCA results did so because they had attended clinic due to symptoms or a family history of disease. However, an increasing number are now learning of their genetic risk after paying for home DNA testing kits or taking part in genetic research, without ever having any personal link with breast cancer. Read full story Source: The Guardian, 15 September 2023
  7. News Article
    A cancer patient with months to live has spoken of her fear and anger after chemotherapy was delayed by this week’s strikes. Flora White, 51, began chemotherapy last month, which is required fortnightly to shrink a tumour so it can be surgically removed. But it has now been set back, after the appointment she was due to have with her oncologist the day before was cancelled as a result of strikes. Ms White said that until she got the devastating news about her own delays she had thought cancer patients would be protected from the impact of industrial action. “It’s hard to deal with as it is, let alone the extra worry and stress,” she said. “Your treatment being cancelled and delayed, they don’t understand how they’re affecting some people.” Earlier this week, Prof Karol Sikora, a leading consultant oncologist, said it was “against the ethics of medicine” for doctors to strike, as he urged medics to think again. “If you miss cancer and someone goes for another two years without a diagnosis, it’s as good as leaving someone in the gutter bleeding ... people will die,” he said. Read full story (paywalled) Source: The Telegraph, 21 September 2023
  8. News Article
    The impact of successive doctors’ strikes is now ‘causing significant disruption and risk to patients’, including to those needing urgent heart and cancer treatment, NHS England leaders have told the BMA in their strongest warnings yet. A letter to the union’s council chair on Tuesday evening, leaked to HSJ, said: “We are increasingly concerned that the cumulative impact of this action is causing significant disruption and risk to patients… “We are extremely concerned that Christmas Day cover is insufficient to ensure appropriate levels of patient safety are being maintained across local health systems. This is particularly the case in the current period of industrial action, with three consecutive Christmas Day levels of service.” Although Christmas Day includes cover for emergency care, the officials said that in practice – with demand above Christmas Day levels, and with successive days and repeated strikes – it was not protecting patients needing urgent care. The letter, signed by NHSE leaders including chief medical officer Sir Steve Powis, and chief nurse Dame Ruth May, goes on: “Secondly, we are becoming increasingly concerned that combined periods of industrial action are impacting on our ability to manage individuals who require time-sensitive urgent treatment, for example cardiac, cancer or cardiovascular patients, or women needing urgent caesarean sections.” Read full story (paywalled) Source: HSJ, 3 October 2023
  9. Content Article
    Women interact with cancer in complex ways, as healthy individuals participating in cancer prevention, as patients, as health professionals, researchers, policymakers, and as unpaid caregivers. In all these domains, women often are subject to overlapping forms of discrimination, such as due to age, race, ethnicity and socio-economic status, that render them structurally marginalised. These myriad factors can restrict a woman’s rights and opportunities to avoid cancer risks, are a barrier to diagnosis and quality cancer care, maintain an unpaid caregiver workforce that is predominantly female, and hinder women’s professional advancement.
  10. Content Article
    In a world where most people wake up with the sun and head to their ‘9 to 5’, night shift work can be a challenge – but can it also be bad for your health? What do those health effects mean for your risk of cancer? Can working night shifts cause cancer? Worldwide Cancer Research presents the evidence.
  11. Event
    until
    Public Policy Projects is holding a roundtable "Improving access to genomic testing and medicine for better outcomes and reduced inequalities" on the 20th September from 10:30am to 12pm on Zoom. This session will be chaired by Parker Moss, Chief Commercial & Partnerships Officer at Genomics England, and will seek to explore how genomic technologies can be better utilised, and how services can be appropriately coordinated, to ensure that emerging technology can be used as a tool for reducing inequalities and bettering the overall standard of care for cancer patients in the NHS. The hosts are looking for individuals from Cancer Alliances, ICB, Genomic Laboratory Hubs, Cell Pathology Centres, and Clinical Diagnostic Centres to attend and share their experiences and views at this session. Find out more and register to attend
  12. Content Article
    To mark this year’s World Patient Safety Day (WPSD), the Royal College of Surgeons of Edinburgh (RCSEd) will be running a series of blogs and Talking Heads on key surgical and dental topics in this area. These have been provided by patients, families and carers, alongside members of the College’s Patient Safety Group, College Council and the wider College fellowship. The College’s eleven Surgical Specialty Boards (SSBs) have been asked to provide blogs on how patient involvement in their individual specialty has helped to drive up standards of care. The blogs will provide examples of how patients and carers can play vital roles in making decisions about their own individual care and also how they can enhance the safety of the healthcare system as a whole by contributing to strategic decisions at organisational level. Two blogs will be released on each day of the College’s week-long WPSD campaign, starting on Monday 11 September and leading up to WPSD on Sunday 17 September. Members and Fellows will have access to these through the College website following the campaign.
  13. Content Article
    The number of under-50s worldwide being diagnosed with cancer has risen by nearly 80% in three decades, according to the largest study of its kind. Global cases of early onset cancer increased from 1.82 million in 1990 to 3.26 million in 2019, while cancer deaths of adults in their 40s, 30s or younger grew by 27%. More than a million under-50s a year are now dying of cancer, the research reveals. Experts are still in the early stages of understanding the reasons behind the rise in cases. The authors of the study, published in BMJ Oncology, say poor diets, alcohol and tobacco use, physical inactivity and obesity are likely to be among the factors. “Since 1990, the incidence and deaths of early onset cancers have substantially increased globally,” the report says. “Encouraging a healthy lifestyle, including a healthy diet, the restriction of tobacco and alcohol consumption and appropriate outdoor activity, could reduce the burden of early onset cancer.”
  14. News Article
    An NHS body is encouraging women with breast cancer from minority backgrounds to take part in more clinical trials, after research found they are under-represented in studies that can offer life-saving treatment. The pilot project, supported by the NHS Race and Health Observatory, is intended to improve representation in breast cancer clinical trials partly through culturally sensitive communications to people from racially diverse backgrounds. Research from the UK Health Security Agency suggests young black women are more likely to have aggressive breast cancer tumours, experience poorer care and have higher mortality rates, but are significantly under-represented in clinical research. Their lack of inclusion in trials could be partly down to distrust of the research process and a lack of knowledge, according to research by the UK’s National Institute for Health Research. The project, which works in conjunction with Macmillan Cancer Support and the pharmaceutical company Roche, will run for a year and look at developing new ways for people with breast cancer to access clinical trials. It will develop action plans to improve representation and provide enhanced support for patients. Read full story Source: The Guardian, 31 August 2023
  15. News Article
    Top young cancer researchers are leaving the UK in a “brain drain” fuelled by the continuing failure to reach an agreement over the EU’s study programme, scientists warn. The two-and-a-half-year delay in joining the £85bn Horizon Europe scheme, the largest collaborative research programme in the world, has “damaged the UK’s reputation” and made it more difficult to attract and retain the brightest researchers into the nation’s labs. Cancer Research UK (CRUK) surveyed 84 cancer specialists about Horizon Europe and found that three-quarters of respondents favoured association with the programme compared with only 11% who wanted the UK to go it alone with the government’s plan B, known as Pioneer. Prof Julian Downward, head of the Oncogene Biology Lab at the Francis Crick Institute in London, said: “We need Horizon Europe very badly. The current situation is damaging UK science every day. We are losing top junior faculty regularly who decide to move to EU countries so they can take up European Research Council grants.” Read full story Source: Guardian, 25 August 2023
  16. News Article
    Women could be screened for cervical cancer every five years instead of every three and as many cancers could still be prevented, a new study suggests. Researchers at King’s College London said that screening women aged 24 to 49 who test negative for human papillomavirus (HPV) at five-year intervals prevented as many cancers as screening every three years. The study of 1.3 million women in England, published in the BMJ, found that women in this age group were less likely to develop clinically relevant cervical lesions, abnormal changes of the cells that line the cervix known as CIN3+, and cervical cancer three years after a negative HPV screen compared to a negative smear test. Lead author Dr Matejka Rebolj, senior epidemiologist at King’s College London, said the results were “very reassuring”. She added: “They build on previous research that shows that following the introduction of HPV testing for cervical screening, a five-year interval is at least as safe as the previous three-year interval. “Changing to five-yearly screening will mean we can prevent just as many cancers as before, while allowing for fewer screens.” Read full story Source: The Independent, 31 May 2022
  17. News Article
    Covid-19 vaccination is effective for cancer patients but protection wanes much more rapidly than in the general population, a large study has found. Vaccine effectiveness is much lower in people with leukaemia or lymphoma, those with a recent cancer diagnosis, and those who have had radiotherapy or systemic anti-cancer treatments within the past year, according to the research published in Lancet Oncology. The authors of the world’s largest real world health system evaluation of Covid-19 in cancer patients highlighted the importance of booster programmes, non-pharmacological strategies, and access to antiviral treatment programmes in order to reduce the risk that Covid-19 poses to cancer patients. Peter Johnson, professor of medical oncology at the University of Southampton and joint author of the study, said, “This study shows that for some people with cancer, covid-19 vaccination may give less effective and shorter lasting protection. This highlights the importance of vaccination booster programmes and rapid access to covid-19 treatments for people undergoing cancer treatments.” Study leader, Lennard Lee, department of oncology, University of Oxford, said, “Cancer patients should be aware that at 3-6months they are likely to have less protection from their coronavirus vaccine than people without cancer. It is important that people with a diagnosis of cancer are up to date with their coronavirus vaccination and have had their spring booster if they are eligible.” Read full story Source: BMJ, 24 May 2022
  18. News Article
    NHS Scotland is to change the way women are called to breast cancer detection appointments after major recent errors in the screening programme. Some eligible for screening were not invited because they had moved between GP practices or were aged over 71 by the time their practice was called. Women aged 50 to 70 are invited for appointments once every three years, based on their GP practice. It emerged hundreds of women in NHS Lothian may have missed screenings. The health board said in January that 369 women considered to have a higher risk of developing the disease may not have received appointments at the right time. A major review of the programme in Scotland has made 17 recommendations to strengthen and improve services. They include: A more "person-centred" approach based on calling individual women - rather than the GP practice where they are registered - to set their next test date. Greater flexibility of appointments to provide better access and uptake, with more contact such as texts or phone calls to keep appointments on patients' radar. An online appointment cancellation and rebooking system to provide greater individual convenience. Evening and weekend appointments and more availability in rural and semi-urban locations. Read full story Source: BBC News, 24 May 2022
  19. News Article
    Obese adults in Britain are on course to outnumber those who are a healthy weight within five years, a stark report has revealed. Experts have warned there will be a “tipping point” in 2027 when one third of adults will be obese if current trends continue. By 2040, they predict there will 21 million people classed as obese in the UK, and 19 million deemed to be overweight. The analysis by Cancer Research UK shows seven in 10 (71%) people will be overweight or obese by 2040. Of this, almost four in 10 (36%) adults will be obese. At present, 64% of adults are overweight or obese, with figures rising every year. Being overweight or obese increases the risk of at least 13 different types of cancer and also causes other conditions such as high blood pressure and Type 2 diabetes. The new data comes after former Conservative leader William Hague attacked the government for postponing a ban on “buy one get one free” deals for foods high in fat, salt and sugar for a year because of the cost-of-living crisis. Read full story Source: The Independent, 19 May 2022
  20. News Article
    The NHS will miss its target to return cancer treatment waits to pre-covid levels by next March, a national cancer leader has said. When asked at the HSJ Cancer Forum whether the service would be back to “business as usual” performance by next spring, Liz Bishop, who sits on NHS England’s national cancer board, said: “I think it depends on what you mean by ‘business as usual’. “If you mean hitting the 62-day numbers, and the 104-day numbers, by next March, then no. If I am honest, I don’t think we will. “Do I know when that date will be? No, I don’t know. But what I do know is that everyone is working really hard to do it and get there.” NHSE initially said the number of patients waiting longer than 62 days for treatment following an urgent referral would return to pre-pandemic levels by March this year, but has since pushed this back to March 2023. Read full story (paywalled) Source: HSJ, 18 March 2022
  21. News Article
    New calculations from Cancer Research UK estimate that, on average, over 65,000 people in England are left waiting longer than 28 days to find out whether they have cancer each month. These estimates are based on the latest data from the Faster Diagnosis Standard (FDS). The FDS is a performance standard introduced by Government in 2021. It’s used to better capture how long people on certain cancer-related referrals wait for a diagnosis. This applies to people referred by their GP urgently with suspected cancer, following breast symptoms, or have been picked up through cancer screening. The current FDS target is set at 75%, meaning three quarters of people being urgently referred should be told they have cancer or given the all-clear within that timeframe. However, this target has yet to be met. In addition, the data has revealed major variation across the country – with only 78 of 143 trusts meeting the 75% target. This means that despite the tireless efforts of NHS staff, chronic capacity issues mean that people continue to be failed by the system. Michelle Mitchell, our chief executive, said: “As a country we should not be willing to accept that over 1 in 4 people on an urgent referral are left waiting over a month to find out whether they have cancer. Nor should we stand for the variation that exists across the country.” The charity is calling on Government to include a more ambitious target within its upcoming 10-year cancer plan, to help ensure around 54,300 more people each month receive a diagnosis or have cancer ruled out within a month. With a robust plan and sustained investment to build a cancer workforce fit for the future, patients will be diagnosed quicker and earlier, which will save more lives. Read full story Source: Cancer Research UK, 9 May 2022
  22. News Article
    A record 2.7 million people were referred for cancer checks in the last year, NHS England has said. It comes after figures suggested the Covid pandemic saw numbers dramatically decline in 2020. But at least 30,000 people are still waiting to start treatment. Charities have welcomed the increase in referrals but warned of the "devastating" impact the pandemic has had on cancer care. Referrals for suspected cancer remain at about 16% higher than pre-pandemic levels and rose overall from 2.4 million to 2,65m in the past 12 months. Dame Cally Palmer, national cancer director for NHS England, said there were still 30,000 people who had not started treatment due to the pandemic but that the new figures suggested some progress. She said: "We are going further and faster than ever before in our ambitions to diagnose more cancers at an earlier stage so that we can save more lives." It is "vital that we keep these referral rates high", she added. Read full story Source: BBC News, 2 May 2022
  23. News Article
    Analysis of thousands of tumours has unveiled a treasure trove of clues about the causes of cancer, representing a significant step towards the personalisation of treatment, a study suggests. Researchers say that for the first time it is possible to detect patterns – called mutational signatures – in the DNA of cancers. These provide clues including about whether a patient has had past exposure to environmental causes of cancer such as smoking or UV light, for example. This is important as these signatures allow doctors to look at each patient’s tumour and match it to specific treatments and medications. Dr Andrea Degasperi, research associate at the University of Cambridge and first author, said: “Whole genome sequencing gives us a total picture of all the mutations that have contributed to each person’s cancer. “With thousands of mutations per cancer, we have unprecedented power to look for commonalities and differences across NHS patients, and in doing so we uncovered 58 new mutational signatures and broadened our knowledge of cancer.” The findings are now being incorporated into the NHS as researchers and clinicians now have the use of a digital tool called FitMS that will help them identify the mutational signature and potentially inform cancer management more effectively. Read full story Source: The Independent, 21 April 2022 You may also be interested to read hub blog: Genetic profiling and precision medicine – the future of cancer treatment
  24. News Article
    NHS leaders are urging people to attend vital lung cancer check-ups as figures reveal almost two-thirds of those invited are not coming forward. The NHS targeted lung health check service offered in some parts of England aims to help diagnose cancer at an earlier stage when treatment may be more successful. Current and former smokers aged between 55 and 74 are invited to speak to a healthcare professional and, if they have a higher chance of developing lung cancer, are offered a scan of their lungs. Doctors are keen to reach those who may not have sought help for symptoms during the pandemic and could be living with undiagnosed lung cancer. People diagnosed at the earliest stage are nearly 20 times more likely to survive for five years than those whose cancer is caught late, according to the NHS. The NHS has already diagnosed 600 people with the disease in travelling trucks, which visit convenient community sites across the UK, such as supermarkets and sports centres, aiming to make it easier for people to access check-ups. But figures show only a third (35%) of patients go to their lung health check when invited by the NHS. “These lung checks can save lives,” said Dame Cally Palmer, the NHS cancer director. “By going out into communities we find more people who may not have otherwise realised they have lung cancer, with hundreds already diagnosed and hundreds of thousands due to be invited." Read full story Source: The Guardian, 19 April 2022
  25. News Article
    More than a quarter of cancers in Northern Ireland are being diagnosed in hospital emergency departments, according to Cancer Research UK. The study, published in The Lancet Oncology, was supported by NI Cancer Registry at Queen's University Belfast. It looked at 857,068 cases diagnosed between 2012 and 2017 in six countries including Australia, Denmark and the UK. Clare Crossey, 35, from Lurgan was diagnosed with acute myeloid leukaemia in February 2018 after being admitted to hospital as an emergency. The 35-year-old mother-of-two, who is a domiciliary care assistant, suddenly became very unwell with symptoms including tiredness and bruising. She told BBC News NI she had contacted her local health centre, where a GP told her she was being overly anxious. Ms Crossey said she had panicked, fearing she may have leukaemia after looking up her symptoms on the internet. "I had a feeling that things weren't right," she said. "The doctor did not agree with my suspicions as they passed me the number of the Samaritans helpline, a prescription for beta blockers and told me to wait a week for blood tests." She said: "I went to Craigavon's A&E, they did blood tests and within hours a consultant broke the news to me that I might have leukaemia." The medical team told her that had she waited any longer to come to the emergency department, she could have died, said Ms Crossley. Barbara Roulston, from Cancer Research UK, said the study confirmed too many people were only being diagnosed with cancer once their health had deteriorated to a point when they needed to go to their emergency department. "We need to reduce the number of cancer diagnoses that are happening in this way," she said. "That means renewed focus on early diagnosis and prevention through things like better awareness of symptoms, better uptake of screening programs and the way to do that is to get funding for the cancer strategy which was published recently. "If we don't, the risk is that we will start to see cancer survival going backwards." Read full story Source: BBC News, 7 April 222
×
×
  • Create New...